Expression patterns of cell cycle proteins in the livers of rats treated with hepatocarcinogens for 28 days

被引:10
作者
Yafune, Atsunori [1 ,2 ,3 ]
Taniai, Eriko [1 ,2 ]
Morita, Reiko [1 ,2 ]
Nakane, Fumiyuki [1 ]
Suzuki, Kazuhiko [1 ]
Mitsumori, Kunitoshi [1 ]
Shibutani, Makoto [1 ]
机构
[1] Tokyo Univ Agr & Technol, Lab Vet Pathol, Fuchu, Tokyo 1838509, Japan
[2] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan
[3] Bozo Res Ctr Inc, Gotemba Lab, Shizuoka 4120039, Japan
关键词
Hepatocarcinogen; Cell cycle; Cytomegaly; Prediction marker; PIPERONYL BUTOXIDE; CARCINOGENESIS; PROLIFERATION; CANCER; APOPTOSIS; LESIONS; MODEL; HETEROCHROMATIN; INVOLVEMENT; METASTASIS;
D O I
10.1007/s00204-013-1011-y
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Some hepatocarcinogens induce cytomegaly, which reflects aberrant cell cycling and increased ploidy, from the early stages of administration to animals. To clarify the regulatory molecular mechanisms behind cell cycle aberrations related to the early stages of hepatocarcinogenesis, we performed gene expression analysis using microarrays and real-time reverse transcription polymerase chain reaction followed by immunohistochemical analysis in the livers of rats treated with the cytomegaly inducing hepatocarcinogens thioacetamide (TAA), fenbendazole, and methyleugenol, the cytomegaly non-inducing hepatocarcinogen piperonyl butoxide (PBO), or the non-carcinogenic hepatotoxicants acetaminophen and alpha-naphthyl isothiocyanate, for 28 days. Gene expression profiling showed that cell cycle-related genes, especially those of G(2)/M phase, were mostly upregulated after TAA treatment. Immunohistochemical analysis was performed on cell cycle proteins that were upregulated by TAA treatment and on related proteins. All hepatocarcinogens, irrespective of their cytomegaly inducing potential, increased liver cells immunoreactive for p21(Cip1), which acts on cells arrested in G(1) phase, and for Aurora B or Incenp, which is suggestive of an increase in a cell population with chromosomal instability caused by overexpression. PBO did not induce cell proliferation after 28-day treatment. Hepatocarcinogens that induced cell proliferation after 28-day treatment also caused an increase in p53(+) cells in parallel with increased apoptotic cells, as well as increased population of cells expressing M phase-related proteins nuclear Cdc2, phospho-Histone H3, and HP1 alpha. These results suggest that hepatocarcinogens may increase cellular populations arrested in G(1) phase or showing chromosomal instability after 28-day treatment. Hepatocarcinogens that induce cell cycle facilitation may cause M phase arrest accompanied by apoptosis.
引用
收藏
页码:1141 / 1153
页数:13
相关论文
共 44 条
[1]   p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]   Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity [J].
Adler, Melanie ;
Mueller, Katja ;
Rached, Eva ;
Dekant, Wolfgang ;
Mally, Angela .
CARCINOGENESIS, 2009, 30 (04) :711-719
[3]   Involvement of glycogen synthase kinase-3β signaling and aberrant nucleocytoplasmic localization of retinoblastoma protein in tumor promotion in a rat two-stage thyroid carcinogenesis model [J].
Ago, Kyohei ;
Saegusa, Yukie ;
Nishimura, Jihei ;
Dewa, Yasuaki ;
Kemmochi, Sayaka ;
Kawai, Masaomi ;
Harada, Tomoaki ;
Mitsumori, Kunitoshi ;
Shibutani, Makoto .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2010, 62 (03) :269-280
[4]   Prediction of rodent carcinogenesis: An evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies [J].
Allen, DG ;
Pearse, G ;
Haseman, JK ;
Maronpot, RR .
TOXICOLOGIC PATHOLOGY, 2004, 32 (04) :393-401
[5]  
[Anonymous], 2000, Natl Toxicol Program Tech Rep Ser, V491, P1
[6]  
Aune G, 2011, INT J CLIN EXP PATHO, V4, P444
[7]  
BECKER FF, 1983, JNCI-J NATL CANCER I, V71, P553
[8]   14-3-3σ is required to prevent mitotic catastrophe after DNA damage [J].
Chan, TA ;
Hermeking, H ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1999, 401 (6753) :616-620
[9]  
CLAWSON GA, 1992, CANCER RES, V52, P1304
[10]   Heterochromatin protein 1α: a hallmark of cell proliferation relevant to clinical oncology [J].
De Koning, Leanne ;
Savignoni, Alexia ;
Boumendil, Charlene ;
Rehman, Haniya ;
Asselain, Bernard ;
Sastre-Garau, Xavier ;
Almouzni, Genevieve .
EMBO MOLECULAR MEDICINE, 2009, 1 (03) :178-191